These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1151 related articles for article (PubMed ID: 27906045)

  • 21. Association of the Presence of Anti-Carbamylated Protein Antibodies in Early Arthritis With a Poorer Clinical and Radiologic Outcome: Data From the French ESPOIR Cohort.
    Truchetet ME; Dublanc S; Barnetche T; Vittecoq O; Mariette X; Richez C; Blanco P; Mahler M; Contin-Bordes C; Schaeverbeke T;
    Arthritis Rheumatol; 2017 Dec; 69(12):2292-2302. PubMed ID: 28853240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
    Aletaha D; Alasti F; Smolen JS
    Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting of anti-citrullinated protein/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens.
    Fernandes-Cerqueira C; Ossipova E; Gunasekera S; Hansson M; Mathsson L; Catrina AI; Sommarin Y; Klareskog L; Lundberg K; Rönnelid J; Göransson U; Jakobsson PJ
    Arthritis Res Ther; 2015 Jun; 17(1):155. PubMed ID: 26059223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smoking, the HLA-DRB1 shared epitope and ACPA fine-specificity in Koreans with rheumatoid arthritis: evidence for more than one pathogenic pathway linking smoking to disease.
    Fisher BA; Bang SY; Chowdhury M; Lee HS; Kim JH; Charles P; Venables P; Bae SC
    Ann Rheum Dis; 2014 Apr; 73(4):741-7. PubMed ID: 23505239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.
    Lakos G; Soós L; Fekete A; Szabó Z; Zeher M; Horváth IF; Dankó K; Kapitány A; Gyetvai A; Szegedi G; Szekanecz Z
    Clin Exp Rheumatol; 2008; 26(2):253-60. PubMed ID: 18565246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis.
    Johansson L; Pratesi F; Brink M; Ärlestig L; D'Amato C; Bartaloni D; Migliorini P; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2016 Jun; 18(1):127. PubMed ID: 27255888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
    Murphy D; Mattey D; Hutchinson D
    PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis.
    Gan RW; Trouw LA; Shi J; Toes RE; Huizinga TW; Demoruelle MK; Kolfenbach JR; Zerbe GO; Deane KD; Edison JD; Gilliland WR; Norris JM; Holers VM
    J Rheumatol; 2015 Apr; 42(4):572-9. PubMed ID: 25593232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis-associated autoantibodies in non-rheumatoid arthritis patients with mucosal inflammation: a case-control study.
    Janssen KM; de Smit MJ; Brouwer E; de Kok FA; Kraan J; Altenburg J; Verheul MK; Trouw LA; van Winkelhoff AJ; Vissink A; Westra J
    Arthritis Res Ther; 2015 Jul; 17(1):174. PubMed ID: 26155788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selected cyclic citrullinated peptides derived from the sequence of mutated and citrullinated vimentin (MCV) are targeted by different antibodies subclasses in patients with rheumatoid arthritis in Russian patients.
    Derganova O; Martinez-Gamboa L; Egerer K; Bang H; Fredenhagen G; Roggenbuck D; Esaulenko I; Burmester GR; Chernykh T; Feist E
    Clin Exp Rheumatol; 2014; 32(5):622-9. PubMed ID: 25189876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
    Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
    Ossipova E; Cerqueira CF; Reed E; Kharlamova N; Israelsson L; Holmdahl R; Nandakumar KS; Engström M; Harre U; Schett G; Catrina AI; Malmström V; Sommarin Y; Klareskog L; Jakobsson PJ; Lundberg K
    Arthritis Res Ther; 2014 Aug; 16(4):R167. PubMed ID: 25112157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk Individuals.
    Verheul MK; Böhringer S; van Delft MAM; Jones JD; Rigby WFC; Gan RW; Holers VM; Edison JD; Deane KD; Janssen KMJ; Westra J; Brink M; Rantapää-Dahlqvist S; Huizinga TWJ; van der Helm-van Mil AHM; van der Woude D; Toes REM; Trouw LA
    Arthritis Rheumatol; 2018 Nov; 70(11):1721-1731. PubMed ID: 29781231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs.
    Svendsen AJ; Hjelmborg JV; Kyvik KO; Houen G; Nielsen C; Skytthe A; Junker P
    J Autoimmun; 2013 Mar; 41():120-5. PubMed ID: 23290888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of anti-CCP2 and RF isotypes and their relation to age and disease severity among Sudanese patients with rheumatoid arthritis.
    Elshafie AI; Elbagir S; Aledrissy MIE; Elagib EM; Nur MAM; Rönnelid J
    Clin Rheumatol; 2019 Jun; 38(6):1545-1553. PubMed ID: 30656490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis.
    Kokkonen H; Brink M; Hansson M; Lassen E; Mathsson-Alm L; Holmdahl R; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2015 May; 17(1):125. PubMed ID: 25990747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?
    Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ
    Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.